Diabetes is the fastest growing chronic disease in Australia, with 1.2 million people known to have type 1, type 2 or gestational diabetes.

With the advent of new treatments, the outcomes of myeloma have changed drastically in the past decade.

This review provides GPs with an understanding of acute severe ulcerative colitis evaluation and risk assessment, emphasising surgical management and complementing existing medical methods.

Given its frequent facial involvement, melasma has a significant impact on the quality of life of patients.

It is estimated that 600,000 Australians currently self-medicate with cannabis, with chronic pain a leading indication for such use.

The warm Australian climate and outdoor living pose a unique clinical profile for foot burns, with burn injury mechanisms varying across seasons and within patient subgroups.

This study provides insights into the management of heavy menstrual bleeding (HMB) prior to the release of the HMB clinical care standard.

Long-term management requires an understanding of the range of causes and benefits from a shared decision-making approach, with discussion about potential risks and benefits of therapy.

An awareness of disseminated superficial actinic porokeratosis as a precancerous skin condition is an important component of any Australian general practitioner’s basic skin knowledge.

Promoting insulin as a normal part of the diabetes continuum and a beneficial change for long-term health will further improve patients’ experience during the commencement of insulin.

It is important that a high level of clinical suspicion is maintained when paediatric patients present with a vague history or symptoms that may represent airway foreign bodies.

General practitioners and practice nurses need to be provided with greater support and training to undertake the emotionally challenging role of mandated reporters of child abuse.

It is important for prescribers to regularly ask patients about their medication adherence and to discuss strategies for promoting this.

Patients and physicians need to be aware of the important implications that medical cannabis use may have for driving.

It is unlikely that medicinal cannabis will be used as a first-line agent for the management of pain, nausea and other specific symptoms, but it may have a complementary role within palliative care.